[Chemotherapy of advanced ovarian cancer. Göttingen-Hannover studies].

Abstract

Patients with ovarian carcinoma stages III and IV were treated with cis-platin (P), adriamycin (A) and cyclophosphamide (C). The total rate of remission in group PC (n = 58) was 86% (CR = 55%), in group PA (n = 48) 65% (CR = 48%) and in group PAC (n = 43) 63% (CR 47%). The number of cycles administered were 8 in PA and PAC, and 5 in PC. Half of the patients… (More)

Topics

Cite this paper

@article{Khnle1985ChemotherapyOA, title={[Chemotherapy of advanced ovarian cancer. G{\"o}ttingen-Hannover studies].}, author={H. F. K{\"u}hnle and Joern Hilfrich}, journal={Onkologie}, year={1985}, volume={8 6}, pages={374-82} }